SMi’s 4th Annual Pharmaceutical Microbiology East Coast Conference
Event Apr 28 - Apr 29, 2021
Sponsored by Microcoat
Chaired by Lynne Ensor, Vice President, RCS Head of Global Compliance, Parexel
Exploring Agile Contamination Control Strategy
Biologic products require diligent microbial control because of their complex and sometimes growth-promoting manufacturing processes, and high-risk patient populations. The increase in complexity of pharmaceutical products, rise in development of biologics and increasingly stringent regulations for biologics are some of the factors that are driving the growth of the pharmaceutical microbiology market for biopharmaceutical products.
SMi Group invite all microbiologists to join the virtual conference to discuss Contamination Control Strategies, Effective Environmental Monitoring, and the newest schools of thought in personnel operation. Leaders in regulation and compliance will provide expert viewpoints on how to implement and interpret the regulation, in addition, Annex 1 will be assessed and debated.